- Видео 5
- Просмотров 6 736
Oxford Ageing Network - OxAgeN
Добавлен 20 янв 2019
The Oxford Ageing Network (OxAgeN) is a research consortium at the University of Oxford, focused on basic and applied biomedical research on ageing.
Longevity Venture Capital (LongBio) - Sebastian Brunemeier - Longevity Biotech Fellowship 2023
Sebastian Brunemeier returns to the Longevity Biotech Fellowship to present on venture capital and LongBio company building.
Sebastian A. Brunemeier is a biotech VC and company builder focused on longevity & regenerative medicine. He is Co-Founder and General Partner of Healthspan Capital, and CEO and Founder of ImmuneAGE Bio (stealth), focused on immune system rejuvenation.
Over the last 5 years, he has co-founded 4 longevity biotech (“LongBio”) companies with a total equity value of over $500M. He was Co-Founder and Chief Investment Officer at Cambrian Biopharma, Founder and COO of Samsara Therapeutics, and Principal at Apollo Health Ventures (the first and largest aging-focused venture...
Sebastian A. Brunemeier is a biotech VC and company builder focused on longevity & regenerative medicine. He is Co-Founder and General Partner of Healthspan Capital, and CEO and Founder of ImmuneAGE Bio (stealth), focused on immune system rejuvenation.
Over the last 5 years, he has co-founded 4 longevity biotech (“LongBio”) companies with a total equity value of over $500M. He was Co-Founder and Chief Investment Officer at Cambrian Biopharma, Founder and COO of Samsara Therapeutics, and Principal at Apollo Health Ventures (the first and largest aging-focused venture...
Просмотров: 389
Видео
Scientific Diligence for Longevity Biotech ("LongBio") - Sebastian Brunemeier - On Deck
Просмотров 2142 года назад
Presentation to the On Deck Longevity Biotech Fellowship in 2021 by Sebastian Brunemeier.
Longevity Biotech ("LongBio") and VC Diligence: Sebastian Brunemeier
Просмотров 1,2 тыс.3 года назад
Sebastian A. Brunemeier is a biotech founder focused on the biology of aging. He is CEO of ImmuneAGE Pharma, focused on rejuvenating the immune system. Sebastian was a Principal at Apollo Health Ventures, the first and largest aging-focused venture capital fund in the world, as well as Co-Founder and Chief Investment Officer at Cambrian Biopharma, a diversified drug discovery platform company f...
Brain Ageing Biochemistry & Therapeutics @ Oxford (Sebastian A. Brunemeier)
Просмотров 5433 года назад
The Oxford Ageing & Longevity Society hosts its second talk by Sebastian A. Brunemeier, on "Brain Ageing Biochemistry & Therapeutics." More on the speaker: Sebastian A. Brunemeier is a biotech founder and VC investor focused on the biology of aging. Sebastian was a Principal at Apollo Health Ventures, the first and largest aging-focused venture capital fund in the world, as well as Co-Founder a...
Geroscience: The Biology of Aging @ Oxford (Lord Florey Lecture by Sebastian A. Brunemeier)
Просмотров 4,4 тыс.5 лет назад
Sebastian Aguiar Brunemeier, geroscientist and Principal at Apollo Ventures, delivers the Lord Florey Lecture at Lincoln College, Oxford in November 2018. Sebastian Aguiar was a Clarendon Scholar at Lincoln College, Oxford for his DPhil (PhD) on the biochemistry of aging. 0:10 Introduction: The Geroscience Revolution Parallels to the Antibiotic Revolution, Lord Howard Florey, and leading causes...
Very interesting presentation! Did you test whether a ketogenic diet induces autophagy in humans? Keto and fasting share some common signaling pathways and gene expression signatures. Ketones are a signal for stem cell regeneration in the gut of mice and autophagy might be one of the underlying mechanisms. It would be interesting to test whether we can induce autophagy with that a keto diet low in animal protein, which contains higher amounts of the autophagy-inhibiting amino acids Leu, Arg, Met. I think this is a likely scenario, especially if you combine a keto diet with exercise, which induces autophagy. What are your thoughts on that?
Fantastic talk.
very insightful thanks